biological source
mouse
conjugate
unconjugated
Quality Level
antibody product type
primary antibodies
clone
780-3, monoclonal
species reactivity
human
packaging
antibody small pack of 100 μg
technique(s)
electron microscopy: suitable, flow cytometry: suitable, immunofluorescence: suitable, western blot: suitable
isotype
IgMκ
epitope sequence
Unknown
Protein ID accession no.
Unknown
shipped in
dry ice
target post-translational modification
unmodified
General description
Most eukaryotic genes are expressed as pre-mRNAs that are converted to mRNA by splicing. In this process noncoding sequences (introns) are removed, and coding sequences (exons) are ligated together. Some exons are known to be constitutively spliced and are present in every mRNA produced from a given pre-mRNA. However, many are alternatively spliced to generate variable forms of mRNA from a single pre-mRNA species. Nuclear pre-mRNA splicing is catalyzed by the spliceosome that is a multi-megadalton ribonucleoprotein (RNP) complex. It removes introns from nuclear pre-mRNA. The conformation and composition of spliceosome is shown to be dynamic, which is critical for its high degree of accuracy and flexibility. In most eukaryotes two unique spliceosomes have been described: the U2 -dependent spliceosome that catalyzes the removal of U2-type of introns and the U12-dependent spliceosome that is present only in a subset of eukaryotes and splices U12-type of intron. Introns are removed by two consecutive transesterification reactions. In the first reaction the 2 OH group of the branch adenosine of the intron carries out a nucleophilic attack on the 5 ss, which results in cleavage at this site and ligation of the 5 end of the intron to the branch adenosine, forming a lariat structure. In the second reaction, the 3 ss is attacked by the 3 OH group of the 5 exon, which leads to the ligation of the 5 and 3 exons forming the mRNA, and release of the intron. (Ref.: Matera, AG., and Wang, Z. (2014). Nat. Rev. Mol. Cell Biol. 15(2); 108-121; Will, CL., and Luhrmann, R. (2011). Cold Spring Harb. Perspect. Biol. 3(7); a003707; Patel, AA., and Steitz, JA. (2003). Nat. Rev. Mol. Cell Biol. 4(12); 960-970).
Immunogen
Nuclear preparation from U266 human myeloma cells.
Application
Quality Control Testing
Evaluated by Flow Cytometry in permeabilized HeLa cells.
Flow Cytometry Analysis: 2 μg of this antibody detected Nuclear Spliceosomes in one million permeabilized HeLa cells.
Tested Applications
Flow Cytometry Analysis: A representative lot detected Nuclear Spliceosomes in Flow Cytometry applications (Clevenger, C.V., et al. (1985). Cytometry. 6(3): 208-14; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).
Immunofluorescence Analysis: A representative lot detected Nuclear Spliceosomes in Immunofluorescence applications (Clevenger, C.V., et al. (1984). J Histochem Cytochem. 32(7): 757-65; Clevenger, C.V., et al. (1985). Cytometry. 6(3): 208-14; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3):280-6; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).
Western Blotting Analysis: A representative lot detected Nuclear Spliceosomes in Western Blotting applications (Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6; Kumar, P., et al. (2012). PLoS One. 7(8): e42712).
Electron Microscopy: A representative lot detected Nuclear Spliceosomes in Electron Microscopy applications (Clevenger, C.V., et al. (1984). J Histochem Cytochem. 32(7): 757-65; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by Flow Cytometry in permeabilized HeLa cells.
Flow Cytometry Analysis: 2 μg of this antibody detected Nuclear Spliceosomes in one million permeabilized HeLa cells.
Tested Applications
Flow Cytometry Analysis: A representative lot detected Nuclear Spliceosomes in Flow Cytometry applications (Clevenger, C.V., et al. (1985). Cytometry. 6(3): 208-14; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).
Immunofluorescence Analysis: A representative lot detected Nuclear Spliceosomes in Immunofluorescence applications (Clevenger, C.V., et al. (1984). J Histochem Cytochem. 32(7): 757-65; Clevenger, C.V., et al. (1985). Cytometry. 6(3): 208-14; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3):280-6; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).
Western Blotting Analysis: A representative lot detected Nuclear Spliceosomes in Western Blotting applications (Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6; Kumar, P., et al. (2012). PLoS One. 7(8): e42712).
Electron Microscopy: A representative lot detected Nuclear Spliceosomes in Electron Microscopy applications (Clevenger, C.V., et al. (1984). J Histochem Cytochem. 32(7): 757-65; Bauer, K.D., et al. (1986). Cancer Res. 46(5): 2428-34; Clevenger, C.V., et al. (1987). Cytometry. 8(3): 280-6).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Anti-Nuclear Spliceosomes, clone 780-3, Cat. No. MAB1286-I, is a mouse monoclonal antibody that detects Nuclear spliceosomes and is tested for use in Electron Microscopy, Flow Cytometry, Immunofluorescence, and Western Blotting.
Biochem/physiol Actions
Clone 780-3 is a mouse monoclonal antibody that detects human Nuclear spliceosomes.
Physical form
Purified mouse monoclonal antibody IgM in PBS without preservatives.
Preparation Note
Store at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品?
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持